United States (US) Cellular Immunotherapy Market (2025-2031) | Segmentation, Forecast, Trends, Outlook, Analysis, Industry, Value, Competitive Landscape, Size & Revenue, Companies, Share, Growth

Market Forecast By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others), By End Use (Hospitals, Cancer Institutes, Others) And Competitive Landscape
Product Code: ETC9962077 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Cellular Immunotherapy Market Outlook
  • Market Size of United States (US) Cellular Immunotherapy Market, 2024
  • Forecast of United States (US) Cellular Immunotherapy Market, 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Revenues & Volume for the Period 2021- 2031
  • United States (US) Cellular Immunotherapy Market Trend Evolution
  • United States (US) Cellular Immunotherapy Market Drivers and Challenges
  • United States (US) Cellular Immunotherapy Price Trends
  • United States (US) Cellular Immunotherapy Porter's Five Forces
  • United States (US) Cellular Immunotherapy Industry Life Cycle
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Therapy Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By CAR T Cell Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Dendritic Cell Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By NK Cell Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By TIL Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By B-cell Malignancies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Prostate Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Renal Cell Carcinoma for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By End Use for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Cancer Institutes for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cellular Immunotherapy Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Cellular Immunotherapy Import Export Trade Statistics
  • Market Opportunity Assessment By Therapy Type
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By End Use
  • United States (US) Cellular Immunotherapy Top Companies Market Share
  • United States (US) Cellular Immunotherapy Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Cellular Immunotherapy Company Profiles
  • United States (US) Cellular Immunotherapy Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Cellular Immunotherapy Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Cellular Immunotherapy Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Cellular Immunotherapy Market - Industry Life Cycle

3.4 United States (US) Cellular Immunotherapy Market - Porter's Five Forces

3.5 United States (US) Cellular Immunotherapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.6 United States (US) Cellular Immunotherapy Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 United States (US) Cellular Immunotherapy Market Revenues & Volume Share, By End Use, 2021 & 2031F

4 United States (US) Cellular Immunotherapy Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Cellular Immunotherapy Market Trends

6 United States (US) Cellular Immunotherapy Market, By Types

6.1 United States (US) Cellular Immunotherapy Market, By Therapy Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Therapy Type, 2021- 2031F

6.1.3 United States (US) Cellular Immunotherapy Market Revenues & Volume, By CAR T Cell Therapy, 2021- 2031F

6.1.4 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Dendritic Cell Therapy, 2021- 2031F

6.1.5 United States (US) Cellular Immunotherapy Market Revenues & Volume, By NK Cell Therapy, 2021- 2031F

6.1.6 United States (US) Cellular Immunotherapy Market Revenues & Volume, By TIL Therapy, 2021- 2031F

6.1.7 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Cellular Immunotherapy Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Cellular Immunotherapy Market Revenues & Volume, By B-cell Malignancies, 2021- 2031F

6.2.3 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.4 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.2.5 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Renal Cell Carcinoma, 2021- 2031F

6.2.6 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Cellular Immunotherapy Market, By End Use

6.3.1 Overview and Analysis

6.3.2 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Cancer Institutes, 2021- 2031F

6.3.4 United States (US) Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Cellular Immunotherapy Market Import-Export Trade Statistics

7.1 United States (US) Cellular Immunotherapy Market Export to Major Countries

7.2 United States (US) Cellular Immunotherapy Market Imports from Major Countries

8 United States (US) Cellular Immunotherapy Market Key Performance Indicators

9 United States (US) Cellular Immunotherapy Market - Opportunity Assessment

9.1 United States (US) Cellular Immunotherapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.2 United States (US) Cellular Immunotherapy Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 United States (US) Cellular Immunotherapy Market Opportunity Assessment, By End Use, 2021 & 2031F

10 United States (US) Cellular Immunotherapy Market - Competitive Landscape

10.1 United States (US) Cellular Immunotherapy Market Revenue Share, By Companies, 2024

10.2 United States (US) Cellular Immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All